Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.
Luker GD, Yang J, Richmond A, Scala S, Festuccia C, Schottelius M, Wester HJ, Zimmermann J. Luker GD, et al. Among authors: scala s. J Leukoc Biol. 2021 May;109(5):969-989. doi: 10.1002/JLB.2BT1018-715RR. Epub 2020 Oct 26. J Leukoc Biol. 2021. PMID: 33104270 Free PMC article. Review.
Human melanoma metastases express functional CXCR4.
Scala S, Giuliano P, Ascierto PA, Ieranò C, Franco R, Napolitano M, Ottaiano A, Lombardi ML, Luongo M, Simeone E, Castiglia D, Mauro F, De Michele I, Calemma R, Botti G, Caracò C, Nicoletti G, Satriano RA, Castello G. Scala S, et al. Clin Cancer Res. 2006 Apr 15;12(8):2427-33. doi: 10.1158/1078-0432.CCR-05-1940. Clin Cancer Res. 2006. PMID: 16638848
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases.
Portella L, Vitale R, De Luca S, D'Alterio C, Ieranò C, Napolitano M, Riccio A, Polimeno MN, Monfregola L, Barbieri A, Luciano A, Ciarmiello A, Arra C, Castello G, Amodeo P, Scala S. Portella L, et al. Among authors: scala s. PLoS One. 2013 Sep 13;8(9):e74548. doi: 10.1371/journal.pone.0074548. eCollection 2013. PLoS One. 2013. PMID: 24058588 Free PMC article.
A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.
D'Alterio C, Avallone A, Tatangelo F, Delrio P, Pecori B, Cella L, Pelella A, D'Armiento FP, Carlomagno C, Bianco F, Silvestro L, Pacelli R, Napolitano M, Iaffaioli RV, Scala S. D'Alterio C, et al. Among authors: scala s. Int J Cancer. 2014 Jul 15;135(2):379-90. doi: 10.1002/ijc.28689. Epub 2014 Jan 10. Int J Cancer. 2014. PMID: 24375277 Free article.
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
Ieranò C, Santagata S, Napolitano M, Guardia F, Grimaldi A, Antignani E, Botti G, Consales C, Riccio A, Nanayakkara M, Barone MV, Caraglia M, Scala S. Ieranò C, et al. Among authors: scala s. Cell Death Dis. 2014 Jul 3;5(7):e1310. doi: 10.1038/cddis.2014.269. Cell Death Dis. 2014. PMID: 24991762 Free PMC article.
CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
Circelli L, Sciammarella C, Guadagno E, Tafuto S, del Basso de Caro M, Botti G, Pezzullo L, Aria M, Ramundo V, Tatangelo F, Losito NS, Ieranò C, D'Alterio C, Izzo F, Ciliberto G, Colao A, Faggiano A, Scala S. Circelli L, et al. Among authors: scala s. Oncotarget. 2016 Apr 5;7(14):18865-75. doi: 10.18632/oncotarget.7738. Oncotarget. 2016. PMID: 26934559 Free PMC article.
246 results